Cargando…
Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298323/ https://www.ncbi.nlm.nih.gov/pubmed/34605127 http://dx.doi.org/10.1111/dom.14564 |
| _version_ | 1784750679920738304 |
|---|---|
| author | Pieber, Thomas R. Bajaj, Harpreet S. Heller, Simon R. Jia, Ting Khunti, Kamlesh Klonoff, David C. Ladelund, Steen Leiter, Lawrence A. Wagner, Lily Philis‐Tsimikas, Athena |
| author_facet | Pieber, Thomas R. Bajaj, Harpreet S. Heller, Simon R. Jia, Ting Khunti, Kamlesh Klonoff, David C. Ladelund, Steen Leiter, Lawrence A. Wagner, Lily Philis‐Tsimikas, Athena |
| author_sort | Pieber, Thomas R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9298323 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Blackwell Publishing Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92983232022-07-21 Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial Pieber, Thomas R. Bajaj, Harpreet S. Heller, Simon R. Jia, Ting Khunti, Kamlesh Klonoff, David C. Ladelund, Steen Leiter, Lawrence A. Wagner, Lily Philis‐Tsimikas, Athena Diabetes Obes Metab Research Letters Blackwell Publishing Ltd 2021-10-17 2022-02 /pmc/articles/PMC9298323/ /pubmed/34605127 http://dx.doi.org/10.1111/dom.14564 Text en © 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Research Letters Pieber, Thomas R. Bajaj, Harpreet S. Heller, Simon R. Jia, Ting Khunti, Kamlesh Klonoff, David C. Ladelund, Steen Leiter, Lawrence A. Wagner, Lily Philis‐Tsimikas, Athena Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial |
| title | Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial |
| title_full | Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial |
| title_fullStr | Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial |
| title_full_unstemmed | Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial |
| title_short | Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial |
| title_sort | impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine u300 in people with type 2 diabetes: a post hoc analysis of the conclude trial |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298323/ https://www.ncbi.nlm.nih.gov/pubmed/34605127 http://dx.doi.org/10.1111/dom.14564 |
| work_keys_str_mv | AT pieberthomasr impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT bajajharpreets impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT hellersimonr impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT jiating impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT khuntikamlesh impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT klonoffdavidc impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT ladelundsteen impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT leiterlawrencea impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT wagnerlily impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial AT philistsimikasathena impactofkidneyfunctiononthesafetyandefficacyofinsulindegludecversusinsulinglargineu300inpeoplewithtype2diabetesaposthocanalysisoftheconcludetrial |